ArticleBone marrow transplantation2024

Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.

Christopher Strouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.